CD19 and B-cell non-Hodgkin lymphoma: Notably, CTRP9 also enhances T-cell activation, proliferation, and cytokine production in mice (Fig. 8J), and boosts the activity of anti-CD19 CAR-T cells against B-cell lymphoma.